Skip to main content

Table 4 Multiple linear regression analysis of factors associated with the serum CRP concentration

From: Effect of erythropoietin-stimulating agent on uremic inflammation

 

Model 1

Model 2

Model 3

Model 4

Model 5

Variable

Regression coefficient

p value

Regression coefficient

p value

Regression coefficient

p value

Regression coefficient

p value

Regression coefficient

p value

 

Lower

Upper

 

Lower

Upper

 

Lower

Upper

 

Lower

Upper

 

Lower

Upper

 

Age

   

0.124

0.0003

      

0.112

0.0115

    

0.003

0.01

       

0.001

0.01

 

SBP

         

-0.087

0.0228

-0.099

0.0249

          

-0.004

-0.0003

    

CTR

         

0.134

0.0005

0.011

0.8073

          

0.006

0.021

 

-0.008

0.01

 

Albumin

      

−0.262

<0.0001

   

-0.27

<0.0001

       

−0.423

−0.224

    

-0.43

-0.219

 

LDL-C

      

−0.122

0.0027

   

-0.107

0.013

       

−0.003

−0.001

    

-0.003

0.0004

 

HDL-C

     

−0.148

  

0.0003

   

-0.141

0.0009

      

−0.009

 

−0.003

    

-0.009

-0.002

 

Hemoglobin

      

−0.043

0.2889

   

-0.079

0.0761

       

−0.059

0.018

    

-0.078

0.004

 

eGFR

   

0.09

0.0108

      

0.077

 
    

0.005

0.036

       

-0.002

0.038

0.084

ESA

−0.094

0.0086

−0.075

0.0348

−0.131

0.0014

-0.078

0.0447

-0.116

0.0072

 

−0.253

−0.037

 

−0.225

−0.008

 

−0.354

−0.085

 

-0.244

-0.003

 

-0.335

-0.053

 

ARB or ACE-I

−0.054

0.1229

−0.055

0.1159

−0.098

0.0157

-0.054

0.1589

-0.095

0.0258

 

−0.175

0.021

 

−0.175

0.019

 

−0.266

−0.028

 

-0.184

0.03

    

CCB

−0.088

0.0129

−0.09

0.0097

−0.08

0.052

-0.097

0.0133

-0.077

0.0732

 

−0.228

−0.027

 

−0.23

−0.032

 

−0.247

0.001

 

-0.249

-0.029

 

-0.246

0.011

 
  1. SBP; systolic blood pressure, CTR; Cardiothoracic ratio, LDL-C; low density lipoprotein cholesterol, HDL-C; high density lipoprotein cholesterol, eGFR; estimated glomerular filtration rate, ESA; erythropoietin-stimulating agents, ARB; angiotensin-II receptor blockers, ACE-I; angiotensin-converting enzyme inhibitors, CCB; calcium channel blockers.